Drug Discovery & Development
Drug Discovery & Development
Eli Lilly’s Jaypirca (pirtobrutinib) receives expanded indication from US FDA for certain patients with previously untreated CLL/SLL
The US Food and Drug Administration (FDA) has approved an additional indication for Eli Lilly and Company’s Jaypirca (pirtobrutinib, 100 mg & 50 mg tablets),...
Drug Discovery & Development
CSL and Alentis announce global partnership to develop and commercialise lixudebart for rare kidney and liver diseases
CSL and Alentis Therapeutics have entered into an exclusive global collaboration agreement to co-develop and co-promote lixudebart, which has the potential to become a...
Drug Discovery & Development
HanchorBio announces US FDA clearance of IND application for HCB303, a next-generation trispecific immunotherapy
The US Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for HCB303 developed by HanchorBio, a global clinical-stage biotechnology...
Clinical Trials Insights
Lundbeck presents phase 1b data for Lu AF28996 in advanced Parkinson’s disease, as phase 2 trial begins
H Lundbeck has announced results from an open-label phase 1b trial evaluating Lu AF28996, a novel, investigational, oral prodrug of D1-like/D2-like dopamine receptor agonist,...
Drug Discovery & Development
Beactica Therapeutics selects BEA-28 as a preclinical candidate and first-in-class TEAD degrader for biomarker-selected cancers
Beactica Therapeutics AB, a Swedish precision medicine company, has selected BEA-28 as a preclinical candidate for its TEAD programme, which is aimed at developing...
Drug Discovery & Development
Carbogen Amcis announces successful first FDA pre-approval inspection at its Vionnaz site
Carbogen Amcis, a leading pharmaceutical process development and active pharmaceutical ingredient (API) manufacturing company, announces the successful completion of the first US Food and Drug...
Drug Discovery & Development
Thermo Fisher Scientific showcases new solutions and expanded capabilities to accelerate drug development at CPHI Milan 2026
Thermo Fisher Scientific, a world leader in serving science, is expanding its drug development, manufacturing and clinical capabilities to help pharmaceutical and biotechnology companies...
Drug Discovery & Development
Novai publishes study supporting use of DARC imaging technology to identify patients at risk of central vision loss from macular atrophy
Novai, a medtech company combatting blindness and disability by pioneering early detection and intervention for eye and brain diseases, has announced the publication of...
- Advertisement -
- Advertisement -
- Advertisement -
- Advertisement -
